METHOD DEVELOPMENT AND VALIDATION OF IRBESARTAN CHLORTHALIDONE AND CILNIDIPINE IN THEIR COMBINED TABLET DOSAGE FORM BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

Journal Title: Journal of Drug Delivery and Therapeutics - Year 2017, Vol 7, Issue 4

Abstract

The present work describes a validated reverse phase high performance liquid chromatographic method for simultaneous estimation of Irbesartan chlorthalidone and cilnidipine in tablet dosage form. The quantification was carried out using C18 column (250 x 4.6mm, 5μm) and mobile phase comprised of Buffer, Acetonitrile and TEA in a proportion of 80:20:0.1 %v/v/v. The flow rate was 1.0 ml/min and the eluent was monitored at 222 nm. The selected chromatographic conditions were found to effectively separate Irbesartan Chlorthalidone and cilnidipine were 3.807 min, 4.667 min, and 6.887 min respectively. Linearity was found to be in the range of 30-90 μg/ml, 1.25-3.75 μg/ml and 1-3 μg/ml for Irbesartan Chlorthalidone and cilnidipine respectively. The percentage recoveries of all the drugs were found to be 99.27-99.81%, 99.57-99.99% and 99.22-99.44% for Irbesartan, chlorthalidone, and cilnidipine. The proposed method was found to be fast, accurate, precise, and reproducible and can be used for simultaneous estimation of these drugs in a tablet.

Authors and Affiliations

Rishabh K Dagariya

Keywords

Related Articles

FORMULATION OPTIMIZATION AND EVALUATION OF GASTRORETENTIVE TABLETS OF ONDANSETRON HCL

The aim of the work is to design Gastroretentive tablets of Ondansetron HCl for gastric retention by using 32 factorial designs. Floating tablets of Ondansetron HCl were prepared by direct compression method using polyme...

Application of ImageJ for processing Shilajit exposed PBMC images

Objective: In this study, application of ImageJ for processing Shilajit exposed PBMC images were studied. Methods: In present study experiment was designed with human PBMC treated with Shilajit in high concentration (18...

FORMULATION AND DEVELOPMENT OF SUSTAINED RELEASE MATRIX TABLETS OF LORNOXICAM

Lornoxicam is a NSAID having oxicam class mainly prescribed in the treatment of osteoarthritis and rheumatoid arthritis. NSAID have the potential to relieve the pain and inflammation without the immunosuppressive and met...

A NOVEL CLASS OF PHOTOTRIGGERABLE LIPOSOMES CONTAINING PACLITAXEL FOR THE TREATMENT OF SKIN CANCER

Success of nanocarriers-mediated drug delivery solely depends on delivery of therapeutics to a specified target. Secondly therapeutically active amount of drug should be released within defined space and time (triggered...

PREFORMULATION STUDIES OF DILTIAZEM HYDROCHLORIDE FROM TABLETED MICROSPHERES

Microspheres are solid, spherical particles of protein or polymer-based matrix which comprised of a fairly homogeneous mixture of polymer and active agents.It undergoes considerable presystemic metabolism (45-55%) which...

Download PDF file
  • EP ID EP293853
  • DOI 10.22270/jddt.v7i4.1471
  • Views 92
  • Downloads 0

How To Cite

Rishabh K Dagariya (2017). METHOD DEVELOPMENT AND VALIDATION OF IRBESARTAN CHLORTHALIDONE AND CILNIDIPINE IN THEIR COMBINED TABLET DOSAGE FORM BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY. Journal of Drug Delivery and Therapeutics, 7(4), 88-96. https://europub.co.uk./articles/-A-293853